A Proof of Concept Study for a 12 Month Treatment in Patients With C3G or IC-MPGN Treated With ACH-0144471

Name: A Proof of Concept Study for a 12 Month Treatment in Patients With C3G or IC-MPGN Treated With ACH-0144471
Published: 2018
License: Public Domain

Alexion Pharmaceuticals, Inc. · 2018

ClinicalTrials.gov · Datasets · License: Public Domain · 2018

Open Source ↗

c3 glomerulonephritis, c3 glomerulopathy, immune complex membranoproliferative glomerulonephritis, ic-mpgn, dense deposit disease, factor d, fd, alternative pathway, complement mediated disease, c3gn, ddd, idiopathic mpgn

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 807239
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.